CNO Share Price | CNO Financial Group, Inc. Stock Analysis & Recommendation

Q: How big is CNO Financial Group, Inc.?

Market Cap: As of Jun 18, CNO Financial Group, Inc. has a market capitalization of 3,659.31 million, classifying it as a Small Cap company.Recent Quarterly Performance: For the latest four quarters, CNO Financial Group, Inc. reported net sales of 0.00 million and a consolidated net profit of 305.40 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 2,498.40 million and total assets amounting to 34,223.00 million.

Q: What does CNO Financial Group, Inc. do?

Overview:CNO Financial Group, Inc. is a holding company for a group of insurance companies that develops, markets, and administers health insurance, annuity, and individual life insurance products within the insurance industry and operates in the small-cap market.Financial Snapshot:- Most recent Net Profit: 14 Million (Quarterly Results - Mar 2025)- Market-cap: USD 3,659.31 Million (Small Cap)Key Metrics:- P/E: 13.00- Dividend Yield: 148.69%- Debt Equity: -999,999.00- Return on Equity: 12.02%- Price to Book: 1.45Contact Details:- Address: 11825 N PENNSYLVANIA ST, CARMEL IN: 46032- Tel: 1 317 8176100, 1 317 8172893- Fax: 1 302 6365454- Website: http://www.cnoinc.com/

Q: Is CNO Financial Group, Inc. overvalued or undervalued?

As of 30 June 2025, the valuation grade for CNO Financial Group, Inc. moved from expensive to fair, indicating a more favorable assessment of its market position. The company appears to be fairly valued based on its P/E ratio of 13, which is lower than the P/E of 20.92 for Reinsurance Group of America, Inc. and 15.58 for Assurant, Inc. Additionally, its EV to EBITDA ratio stands at 12.49, which is competitive compared to peers like AXIS Capital Holdings Ltd. at 18.60 and MGIC Investment Corp. at 551.79. The high dividend yield of 188.88% further supports the attractiveness of the stock.In terms of recent performance, CNO Financial Group has outperformed the S&P 500 over the 1-month and 3-year periods, with returns of 4.79% and 107.66%, respectively, compared to the S&P 500's 2.33% and 70.41%. Overall, CNO Financial Group is fairly valued, with strong returns and competitive ratios compared to its peers.

Q: Is CNO Financial Group, Inc. technically bullish or bearish?

As of 8 September 2025, the technical trend for CNO Financial Group, Inc. has changed from mildly bullish to sideways. The current stance is neutral, with mixed signals across different indicators. The weekly MACD is bullish, while the monthly MACD is mildly bearish. Bollinger Bands are bullish on both weekly and monthly timeframes. However, the daily moving averages and the weekly OBV show mild bearishness, indicating some weakness. The Dow Theory presents a mixed view, being mildly bearish weekly and mildly bullish monthly. In terms of performance, CNO has outperformed the S&P 500 over the past month (4.79% vs. 2.33%) and over the past year (13.77% vs. 17.14%), but it has lagged behind in the longer-term periods, particularly over 10 years (127.47% vs. 231.64%).

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.76 M

Shareholding (Dec 2025)

FII

6.92%

Held by 140 FIIs

DII

44.27%

Held by 59 DIIs

Promoter

0.03%

How big is CNO Financial Group, Inc.?

22-Jun-2025

As of Jun 18, CNO Financial Group, Inc. has a market capitalization of $3.66 billion, with shareholder's funds of $2.50 billion and total assets of $34.22 billion.

View full answer

What does CNO Financial Group, Inc. do?

22-Jun-2025

CNO Financial Group, Inc. is a holding company for insurance firms that offers health insurance, annuities, and individual life insurance products. As of March 2025, it has a market cap of $3.66 billion and a net profit of $14 million.

View full answer

Who are in the management team of CNO Financial Group, Inc.?

22-Jun-2025

As of March 2022, the management team of CNO Financial Group, Inc. includes Mr. Daniel Maurer (Independent Chairman), Mr. Gary Bhojwani (CEO), and several independent directors: Mr. Steven Shebik, Ms. Ellyn Brown, Mr. Stephen David, Mr. David Foss, and Mr. Robert Greving. They are responsible for the company's strategic direction and governance.

View full answer

Is CNO Financial Group, Inc. overvalued or undervalued?

20-Sep-2025

As of June 30, 2025, CNO Financial Group, Inc. is fairly valued with a P/E ratio of 13, a competitive EV to EBITDA ratio of 12.49, a high dividend yield of 188.88%, and has outperformed the S&P 500 over the past month and three years.

View full answer

Is CNO Financial Group, Inc. technically bullish or bearish?

20-Sep-2025

As of September 8, 2025, CNO Financial Group's trend is neutral with mixed signals, showing mild bullishness in the weekly MACD and Bollinger Bands, but some weakness in daily moving averages and OBV, while it has outperformed the S&P 500 recently but lags in long-term performance.

View full answer

Compare CNO Financial Group, Inc. with Similar Stocks

F&G Annuities & Life, Inc.White Mountains Insurance Group Ltd.Enstar Group Ltd.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 13.01%

Poor long term growth as Net Sales has grown by an annual rate of 3.32% and Operating profit at 0%

Positive results in Jun 25

With ROE of 12.02%, it has a fair valuation with a 1.51 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Insurance

Market cap

USD 3,809 Million (Small Cap)

P/E

13.00

Industry P/E

Dividend Yield

1.75%

Debt Equity

-999,999.00

Return on Equity

10.86%

Price to Book

1.44

Revenue and Profits:

Net Sales:

(Quarterly Results - Dec 2025)

Net Profit:

93 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-7.99%

6 Months

0.4%

1 Year

-2.43%

2 Years

50.93%

3 Years

89.42%

4 Years

61.54%

5 Years

54.93%

CNO Financial Group, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

3.30%

EBIT Growth (5y)

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

21.65%

Dividend Payout Ratio

29.17%

Pledged Shares

Institutional Holding

96.70%

ROCE (avg)

ROE (avg)

13.01%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.44

EV to EBIT

EV to EBITDA

29.05

EV to Capital Employed

1.21

EV to Sales

1.53

PEG Ratio

Dividend Yield

1.75%

ROCE (Latest)

ROE (Latest)

10.86%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

No Trend

Bullish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 85 Schemes (48.73%)

Foreign Institutions

Held by 140 Foreign Institutions (6.92%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -49.21% vs 403.86% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "318.50",
          "val2": "292.40",
          "chgp": "8.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "53.20",
          "val2": "62.00",
          "chgp": "-14.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "92.90",
          "val2": "182.90",
          "chgp": "-49.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "148.00%",
          "val2": "274.60%",
          "chgp": "-12.66%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -43.24% vs 46.11% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "318.50",
          "val2": "292.40",
          "chgp": "8.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "230.90",
          "val2": "254.40",
          "chgp": "-9.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-100.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "229.30",
          "val2": "404.00",
          "chgp": "-43.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "138.80%",
          "val2": "171.30%",
          "chgp": "-3.25%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

318.50

292.40

8.93%

Interest

53.20

62.00

-14.19%

Exceptional Items

-5.20

0.00

Consolidate Net Profit

92.90

182.90

-49.21%

Operating Profit Margin (Excl OI)

148.00%

274.60%

-12.66%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -49.21% vs 403.86% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

318.50

292.40

8.93%

Interest

230.90

254.40

-9.24%

Exceptional Items

-100.40

0.00

Consolidate Net Profit

229.30

404.00

-43.24%

Operating Profit Margin (Excl OI)

138.80%

171.30%

-3.25%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -43.24% vs 46.11% in Dec 2024

All Annual Results

Company CV

About CNO Financial Group, Inc.

CNO Financial Group, Inc.

Insurance

CNO Financial Group, Inc. is a holding company for a group of insurance companies operating throughout the United States that develops, markets and administers health insurance, annuity, individual life insurance and other insurance products. The Company's segments include Bankers Life, Washington National and Colonial Penn. It sells health insurance, annuity, individual life insurance and other insurance products through three primary distribution channels: career agents, independent producers and direct marketing. The Company offers products in various categories, including health, annuities and life insurance. The health products include Medicare supplement, long-term care, prescription drug plan and Medicare advantage, supplemental health products and other health products. The annuities products include fixed index annuities and other fixed interest annuities. The life insurance products include interest-sensitive life products and traditional life products.

Company Coordinates

Company Details

11825 N PENNSYLVANIA ST , CARMEL IN : 46032

Tel: 1 317 81761001 317 8172893

http://www.cnoinc.com/

Registrar Details